| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.062 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |